Organ-on-a-Chip (OOC) technology, which emulates the physiological environment and
functionality of human organs on a microfluidic chip, is undergoing significant technological …

Conventional drug delivery techniques face challenges related to targeting and adverse
reactions. Recent years have witnessed significant advancements in nanoparticle‐based …

Current hydrogel strain sensors have never been integrated into dynamic organ‐on‐a‐chip
(OOC) due to the lack of sensitivity in aqueous cell culture systems. To enhance sensing …

Human organoids-on-chips (OrgOCs) are the synergism of human organoids (HOs)
technology and microfluidic organs-on-chips (OOCs). OOCs can mimic extrinsic …

MXenes and their composites hold great promise in the field of soft and bone tissue
regeneration and engineering (TRE). However, there are challenges that need to be …

Traditional drug development is a long and expensive process with high rates of failure. This
has prompted the pharmaceutical industry to seek more efficient drug development …

Microfluidic is a technology that allows the precise control of fluid in a micro-channel. With its
advantages of high throughput and low cost, microfluidic technology has achieved good …

Cancer is a leading cause of morbidity and mortality worldwide, and an increase in
incidence is estimated in the next future, due to population aging, which requires the …

Many Chinese medicines have shown protective effects on the heart, while their specific
effects and modes of action are still lacking of intuitive studies. In this paper, we propose a …

There is an increasing need for better preclinical therapeutic development models suitable
for the human body. As a result, there has been a shift from traditional animal models to …